Cargando…
Adeno-associated virus-mediated CASQ2 delivery rescues phenotypic alterations in a patient-specific model of recessive catecholaminergic polymorphic ventricular tachycardia
Catecholaminergic Polymorphic Ventricular Tachycardia type 2 (CPVT2) is a highly lethal recessive arrhythmogenic disease caused by mutations in the calsequestrin-2 (CASQ2) gene. We have previously demonstrated that viral transfer of the wild-type (WT) CASQ2 gene prevents the development of CPVT2 in...
Autores principales: | Lodola, Francesco, Morone, Diego, Denegri, Marco, Bongianino, Rossana, Nakahama, Hiroko, Rutigliano, Lucia, Gosetti, Rosanna, Rizzo, Giulia, Vollero, Alessandra, Buonocore, Michelangelo, Napolitano, Carlo, Condorelli, Gianluigi, Priori, Silvia G, Di Pasquale, Elisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133973/ https://www.ncbi.nlm.nih.gov/pubmed/27711080 http://dx.doi.org/10.1038/cddis.2016.304 |
Ejemplares similares
-
CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia
por: Di Pasquale, E, et al.
Publicado: (2013) -
CASQ2 variants in Chinese children with catecholaminergic polymorphic ventricular tachycardia
por: Li, Qirui, et al.
Publicado: (2019) -
Compound heterozygous CASQ2 mutations and long‐term course of catecholaminergic polymorphic ventricular tachycardia
por: Josephs, Katherine, et al.
Publicado: (2017) -
A Homozygous CASQ2 Mutation in a Japanese Patient with Catecholaminergic Polymorphic Ventricular Tachycardia
por: Fujisawa, Taishi, et al.
Publicado: (2019) -
Molecular adaptation to calsequestrin 2 (CASQ2) point mutations leading to catecholaminergic polymorphic ventricular tachycardia (CPVT): comparative analysis of R33Q and D307H mutants
por: Valle, Giorgia, et al.
Publicado: (2020)